Background: Biomarker-driven molecular imaging has emerged as an integral part of cancer
precision radiotherapy. The use of molecular imaging probes, including nanoprobes, have …

Patients with high ALDH1A3-expressing glioblastoma (ALDH1A3 hi GBM) show limited
benefit from postoperative chemoradiotherapy. Understanding the mechanisms underlying …

The gut microbiome has emerged as a crucial player in modulating cancer therapies,
including radiotherapy. In the case of breast cancer, the interplay between the microbiome …

Colorectal cancer (CRC) ranks among the most prevalent malignancies worldwide, driving a
quest for comprehensive characterization methods. We report a characterization of the ex …

Radiotherapy is one of the most common approaches for cancer treatment, especially in the
case of peripheral nervous system tumors. As it requires exposure to high doses of ionizing …

Abstract FLASH radiotherapy (FLASH RT) is an innovative modality in cancer treatment that
delivers ultrahigh dose rates (UHDRs), distinguishing it from conventional radiotherapy …

Despite intensive efforts and refined techniques, overall survival in HPV-negative head and
neck cancer remains poor. Robust immune priming is required to elicit a strong and durable …

Tumor microenvironent contains prognostic molecular markers and therapeutic targets from
different cellular sources, which are still not fully revealed in the resistance and recurrence …

Significance: Glioblastomas (GBMs) are among the most lethal tumors despite the almost
exclusive localization to the brain. This is largely due to therapeutic resistance. Radiation …

An increasing number of scientific papers discuss the promising therapeutic potential of
cannabidiol (CBD) not only for the treatment of cancer, but also for asthma and …